RxDoctor Payments Data

Mouna Abouamara

Internal Medicine · Johnson City, TNNPI 1447324603

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,253 of the $1,412 with a category attached, or 88.7%. It is spread thinly across 25 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $672 and has fallen 97.5% since, to $17 in 2025.

$1,412in general payments, 2019–2025

Across 80 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$198
  • Johnson & Johnson$186
  • GSK$165
  • Novartis$125
  • Merck$80
  • Myovant Sciences Inc.$72
  • plus $587 from 19 others
$45,917in research payments, 2019–2025

Across 3 payments — averaging $15,306 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$27K
  • Astrazeneca UK Limited$19K

What the payments were for

  • Food & beverage$1,25389%
  • Education$15911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,412 in reported general payments places this provider in the 70th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Other internal medicine in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →